Psoriasis

A recent study examined the association between depression and the risk of developing psoriatic arthritis in patients with psoriasis.

The FDA approved the injection Siliq (brodalumab) to treat adults with moderate to severe plaque psoriasis.

A new study examined the long-term effects of weight loss on the severity of psoriasis in participants.

The National Psoriasis Foundation published guidelines for clinicians treating psoriasis as a response to the urgent need for treatment goals in the US.

Obesity is common in patients with dermatologic disorders, and awareness could lead to interventions that may improve their disease and decrease risks of comorbidities, according to a recent study.

The association between psoriasis and increased risk of abdominal aortic aneurysm was assessed in a recent study.

Psoriasis is a ubiquitous chronic inflammatory skin disease that occurs most often in adults, with men and women affected with equal prevalence.

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

Recent research examined the relationship between the severity of psoriasis and vascular inflammation that could lead to heart attack or stroke.